EUVIMEDEUVIMED entdecken
Open Access

Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery

Ivan Isaac iD, Altab Shaikh, Mayurakkhi Bhatia, Qian Liu, Seungman Park, Chandrabali Bhattacharya iD

ACS Nano · 22.10.2024 · 18 (42) · 29045-29058

DOI: 10.1021/acsnano.4c10154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 11.10.2024. Verfasst von Ivan Isaac und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States. Hauptthemen laut MEDLINE: RNA, Messenger, Lipids, Pyrimidines. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, University of Nevada, Las Vegas.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have emerged as an effective and promising technology for messenger RNA (mRNA) delivery, offering a potential solution to physiological barriers and providing an alternative approach to gene therapy without the drawbacks associated with viral delivery. However, efficiently delivering mRNA remains a significant challenge in nucleic acid-based therapies due to the limitations of current LNP platforms in achieving optimal endosomal escape and mRNA release, which largely relies on finding a suitable ionizable lipid. Additionally, the synthesis of these ionizable lipids involves multiple chemical reactions, often making the process time-consuming and difficult to translate. In this study, we employed a facile, catalyst-free, and versatile one-pot multicomponent reaction (MCR) to develop a library of ionizable lipids featuring a pharmacologically significant tetrahydropyrimidine (THP) backbone, tailored for enhanced mRNA delivery. A library of 26 THP ionizable lipids was systematically synthesized in just 3 h and formulated with luciferase mRNA for initial in vitro screening. The THP LNPs exhibited tunable particle sizes, favorable ζ-potentials, and high encapsulation efficiencies. Among them, THP1 demonstrated the highest transfection efficiency both in vitro and in vivo after intramuscular administration, comparable to DLin-MC3-DMA (MC3), a conventional benchmark. Further optimization of THP1 with phospholipids significantly enhanced intramuscular mRNA delivery and showed sustained protein expression in vivo for up to 5 days. More importantly, it demonstrated successful intravenous delivery in a dose-dependent manner with minimal toxicity, as indicated by hematological, histopathological, and proinflammatory cytokine assessments. Furthermore, THP1 LNPs also demonstrated the ability to edit genes in specific liver tissues in a tdTomato transgenic mouse model, highlighting their precision and utility in targeted therapeutic applications. These findings position THP1 LNPs as promising candidates for advancing mRNA-based therapies, with significant implications for clinical translation in vaccine delivery and CRISPR/Cas9-mediated gene editing in the liver.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, MessengerLipidsPyrimidinesAnimalsMiceHumansNanoparticlesGene Transfer TechniquesParticle SizeTransfectionLiposomes

Stichwörter der Autor:innen

biomaterialsin vivo deliveryionizable lipidlipid nanoparticlesmRNAmulticomponent reactiontetrahydropyrimidine

Substanzen

RNA, MessengerLipidsPyrimidinesLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
  • Nevada Institute of Personalized Medicine, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
  • School of Life Sciences, College of Sciences, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
  • Department of Mechanical Engineering, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.
  • Interdisciplinary Biomedical Engineering Program, University of Nevada, Las Vegas, Las Vegas, Nevada 89154, United States.

ORCID-Profile: Ivan Isaac, Chandrabali Bhattacharya

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • University of Nevada, Las Vegas
  • National Institute on Aging
  • Pharmaceutical Research and Manufacturers of America Foundation
  • National Institute of General Medical Sciences

Zitieren

APA

Isaac, I., Shaikh, A., Bhatia, M., Liu, Q., Park, S., & Bhattacharya, C. (2024). Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery. ACS Nano, 18(42), 29045-29058. https://doi.org/10.1021/acsnano.4c10154

Vancouver

Isaac I, Shaikh A, Bhatia M, Liu Q, Park S, Bhattacharya C. Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery. ACS Nano. 2024;18(42):29045-29058. doi:10.1021/acsnano.4c10154

BibTeX
@article{Isaac2024,
  author = {Isaac, Ivan and Shaikh, Altab and Bhatia, Mayurakkhi and Liu, Qian and Park, Seungman and Bhattacharya, Chandrabali},
  title = {Tetrahydropyrimidine Ionizable Lipids for Efficient mRNA Delivery},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {42},
  pages = {29045--29058},
  doi = {10.1021/acsnano.4c10154}
}
Kostenlos starten →